Overview
Highlights
- 1Scientific reports · 2024
- 2Scientific reports · 2022
- 3Menopause (New York, N.Y.) · 2025
Publications
Funding
Active
4 grants- PIU01AG095263-01Transforming Alzheimer's Risk Factor Therapeutics into Precision Combination Therapies to Treat ADNIA · 2026–2031 · via NIH RePORTER
- Sub-PIR01AG075122-04PhytoSERM Efficacy to Prevent Menopause Associated Decline in Brain Metabolism and Cognition: A Double-Blind, Randomized, Placebo-Controlled Phase 2 Clinical TrialNational Institute on Aging · 2022–2027 · via University of Arizona
- Sub-PIP01AG026572-19Perimenopause in Brain Aging and Alzheimer's diseaseNational Institute on Aging · 2016–2026 · via University of Arizona· 3 renewals
- KPS10OD034271-01New PET/CT System for Human and Non-human Primate ImagingOffice of the Director, NIH · 2023–2026
Completed grants (12)
- KPS10OD027039-01A17T Magnetic Resonance Imaging System for Basic, Translational and Clinical ResearchOffice of the Director, NIH · 2021–2025
- Sub-PIR01AG057931-05Sex Differences in the Molecular Determinants of Alzheimer’s Disease RiskNational Institute on Aging · 2018–2024 · via University of Arizona· 2 renewals
- Sub-PIR01AG055624-05Modifiable cardiovascular factors linking type 2 diabetes and Alzheimer'sNational Institute on Aging · 2018–2024 · via New York University
- MPICTSC Internal Funding UL1Clinical and Translational Science Center- Institutional CTSC Internal Funding UL1CTSC Cost Share · 2017–2022
- Sub-PIR21AG061579-02Neuroenergetic Adaptations in Alzheimer's Disease: Implications on Amyloid Burden and CognitionNational Institute on Aging · 2019–2022 · via New York University School of Medicine (Grossman)
- PISA 202163-01ADMdx Statement of WorkADM Diagnostics, Inc. (ADMdx) · 2020–2022Contract
- PICAF 183574-02Alzheimer’s risk is higher in women: identification of female-specific bioenergetic targetsCure Alzheimer’s Fund · 2018–2021
- Co-IR56AG064873-01Understanding the dynamic interactions between tau pathology and microglia-mediated inflammation in Alzheimer's DiseaseNational Institute on Aging · 2019–2021
- MPIR01AG035137-05History of Alzheimer predisposes children to amyloid beta-related hypometabolismNIA · 2010–2017 · via NIH RePORTER
- PIP41RR013642-14PRECLINICAL DETECTION OF AD (ABBREAVIATE AS FAMHXAD)NCRR · 2011–2012 · via NIH RePORTER
- PIR21AG032554-02Family History of Alzheimer's, Hypometabolism and Oxidative StressNIA · 2008–2011 · via NIH RePORTER
Clinical research
Active
1 study- PINCT05664477PhytoSERM Efficacy to Prevent Menopause Associated Decline in Brain Metabolism and Cognition: A Double-Blind, Randomized, Placebo-Controlled Phase 2 Clinical TrialPHASE2 · University of Arizona · OPEN TO ACCRUAL (as of 2023)Menopause; Cognitive Change; Brain Disorder, Metabolic
News mentions
- Scans Show Brain's Estrogen Activity Changes During MenopauseJune 20, 2024
The transition to menopause is marked by a progressively higher density of estrogen receptors (ER) on brain cells, a measure that remains elevated in women up to their mid-60s, according to a new brain imaging study led by researchers at Weill Cornell Medicine.
- Study Suggests Estrogen to Prevent Alzheimer’s Warrants Renewed Research InterestOctober 23, 2023
Estrogen-based menopause hormone therapy for women in mid-life should be investigated more thoroughly as a potential strategy for preventing Alzheimer’s disease, the most common form of dementia, according to a new analysis from researchers at Weill Cornell Medicine.
- For Women, Greater Exposure to Estrogen in Life May Protect Brain Regions That Are Vulnerable to Alzheimer’sNovember 3, 2021
The drop in estrogen levels that occurs with menopause brings declines in the volumes of “gray matter,” the cellular matter of the brain, in key brain regions that are also affected in Alzheimer’s disease. But a new study from Weill Cornell Medicine researchers, in collaboration with the University of Arizona, suggests that greater cumulative exposure to estrogen in life
- Imaging Study Reveals Brain Changes During the Transition to MenopauseJune 9, 2021
The transition from pre- to post-menopause, with its steep decline in estrogen production, involves myriad changes to brain structure, brain-region connectivity, and brain energy consumption, though many of these changes are only temporary, a study led by researchers at Weill Cornell Medicine has found.
- Gender DisparityApril 10, 2019
Neuroscientist Dr. Lisa Mosconi explores why women have a much higher risk of Alzheimer’s disease than men.
Media highlights
- At 58, I Had Early Signs Of Alzheimer’s In My Brain. These Interventions Got Rid Of ThemTODAY · November 3, 2026
- Women Have A Higher Risk For Alzheimer’s Than Men Do—Experts Explain Why, And How You Can Protect Your BrainPrevention · September 25, 2026
- Hormone Replacement Therapy: When Is It Good For The Brain?Alzforum · September 24, 2026